Die Thoraxklinik Heidelberg ist eine Lungenfachklinik und gehört zum Universitätsklinikum Heidelberg. Sie befindet sich im Heidelberger Stadtteil Rohrbach.

During the past decade, Thoraxklinik Heidelberg gGmbH conducted 106 clinical trials. In the 10-year time frame, 106 clinical trials started and 48 clinical trials were completed, i.e. on average, 45.3% percent of trials that started reached the finish line to date. In the past 5 years, 47 clinical trials started and 33 clinical trials were completed. i.e. 70.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Thoraxklinik Heidelberg gGmbH" #1 sponsor was "Heidelberg University" with 20 trials, followed by "Hoffmann-La Roche" with 14 trials sponsored, "Boehringer Ingelheim" with 13 trials sponsored, "Actelion" with 12 trials sponsored and "Aeris Therapeutics" with 12 trials sponsored. Other sponsors include 101 different institutions and companies that sponsored additional 67 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Thoraxklinik Heidelberg gGmbH" #1 collaborator was "AstraZeneca" with 4 trials as a collaborator, "PneumRx, Inc." with 4 trials as a collaborator, "Thoraxklinik-Heidelberg gGmbH" with 3 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator and "Heidelberg University" with 2 trials as a collaborator. Other collaborators include 33 different institutions and companies that were collaborators in the rest 41 trials.

According to Clinical.Site data, the most researched conditions in "Thoraxklinik Heidelberg gGmbH" are "Carcinoma, Non-Small-Cell Lung" (15 trials), "Idiopathic Pulmonary Fibrosis" (15 trials), "Emphysema" (13 trials), "Pulmonary Arterial Hypertension" (13 trials) and "Lung Cancer" (11 trials). Many other conditions were trialed in "Thoraxklinik Heidelberg gGmbH" in a lesser frequency.

Most popular intervention types in "Thoraxklinik Heidelberg gGmbH" are "Drug" (98 trials), "Device" (42 trials), "Other" (13 trials), "Biological" (11 trials) and "Radiation" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (35 trials), "Pemetrexed" (11 trials), "Carboplatin" (10 trials), "Cisplatin" (8 trials) and "Nintedanib" (7 trials). Other intervention names were less common.

The vast majority of trials in "Thoraxklinik Heidelberg gGmbH" are 169 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Thoraxklinik Heidelberg gGmbH". undefined are not yet recruiting, 28 are recruiting, 21 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 81 completed trials in Thoraxklinik Heidelberg gGmbH, undefined suspended trials, and 25 terminated clinical trials to date.

Out of the total trials that were conducted in Thoraxklinik Heidelberg gGmbH, 12 "Phase 1" clinical trials were conducted, 46 "Phase 2" clinical trials and 62 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 11 trials, and there were also 31 trials that are defined as “Not Applicable".

Thoraxklinik Heidelberg gGmbH has several departments that took part in Clinical trials: "Thoraxklinik Heidelberg, Dept. of Pneumology and Respiratory Critical care" - 2 trials, "Thoraxklinik-Heidelberg Zentrum für Pulmonale Hypertonie" - 2 trials